BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15067250)

  • 1. [Pharyngoesophagolaryngeal metastases of medullary thyroid carcinoma. A case report].
    Desuter G; Schmitz S; Jamar F; Weynand B; Rahier J; Hamoir M
    Ann Endocrinol (Paris); 2003 Dec; 64(6):448-52. PubMed ID: 15067250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical strategy for the treatment of medullary thyroid carcinoma.
    Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
    Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
    Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
    Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer.
    Kim HK; Bae WK; Choi YD; Shim HJ; Yoon JH; Kang HC
    Thyroid; 2014 Mar; 24(3):599-603. PubMed ID: 23985043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical approach to recurrent papillary thyroid carcinoma involving the larynx: a case report].
    Akbay E
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):246-9. PubMed ID: 19052494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medullary thyroid carcinoma].
    De Medici A; Zucchermaglio MT; Mottola P; Cebrelli CF
    Minerva Chir; 1999 May; 54(5):343-54. PubMed ID: 10443116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of sporadic medullary thyroid cancer.
    Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
    J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-operation for recurrent lymph node metastasis of medullary thyroid cancer--is it useful?
    Vriens B; Van Hee R
    Acta Chir Belg; 2007 Jun; 107(3):331-5. PubMed ID: 17685266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The routine immunohistochemical diagnosis and surgical treatment of medullary carcinoma of the thyroid].
    Gavrailov M; Petkov R; Mladenov B; Todorov G; Kŭtev N
    Khirurgiia (Sofiia); 1995; 48(2):17-9. PubMed ID: 8531439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can procalcitonin be useful for medullary thyroid cancer?
    Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L
    Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroendocrine carcinoma of the larynx with secretion of calcitonin: primary tumor or metastasis of the medullary thyroid carcinoma?].
    Vildé F; Arkwright S; Paoli C; Périchon I; Le Charpentier Y; Le Bodic MF
    Ann Pathol; 1996; 16(2):104-7. PubMed ID: 8767676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
    Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
    Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reoperation for recurrent or persistent medullary thyroid cancer.
    Moley JF; Wells SA; Dilley WG; Tisell LE
    Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hypercalcitoninemia in patients with medullary thyroid cancer.
    Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; Giammartino C; Sanguinetti A; d'Ajello M; Ragusa M; Avenia N
    Tumori; 2009; 95(4):484-7. PubMed ID: 19856661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary metastasis from medullary carcinoma of thyroid: case report and review of literature.
    Bhatoe HS; Badwal S; Dutta V; Kannan N
    J Neurooncol; 2008 Aug; 89(1):63-7. PubMed ID: 18408891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.
    Peixoto Callejo I; Américo Brito J; Zagalo CM; Rosa Santos J
    Clin Transl Oncol; 2006 Jun; 8(6):435-43. PubMed ID: 16790397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.